248652055	248652055	CD	B-NP	O
|	|	NN	I-NP	O
CM	CM	NN	I-NP	O
|	|	NN	I-NP	O
07563073	07563073	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5027467	5027467	CD	B-NP	O
|	|	CC	I-NP	O
8/29/2005	8/29/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/23/2005	1/23/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
DELPINO	DELPINO	NNP	B-NP	O
,	,	,	O	O
VANCE	VANCE	NNP	B-NP	O
SAMMY	SAMMY	NNP	I-NP	O
MD	MD	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
on	on	IN	B-PP	O
Cardiac	Cardiac	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
Service	Service	NNP	I-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Heart	Heart	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Feddes	Feddes	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
56-year-old	56-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
past	past	JJ	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
obesity	obesity	NN	B-NP	O
and	and	CC	O	O
idiopathic	idiopathic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
7/20/05	7/20/05	CD	B-NP	O
for	for	IN	B-PP	O
one-week	one-week	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Medicine	Medicine	NNP	I-NP	O
Service	Service	NNP	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
requiring	require	VBG	I-VP	O
increasing	increase	VBG	B-NP	O
pressors	pressor	NNS	I-NP	O
and	and	CC	O	O
progressing	progress	VBG	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
CHF	CHF	NN	I-NP	B-protein
despite	despite	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
and	and	CC	O	O
appropriate	appropriate	JJ	B-NP	O
management	management	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
1/10/05	1/10/05	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
transplant	transplant	NN	I-NP	O
heart	heart	NN	I-NP	O
became	become	VBD	B-VP	O
available	available	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
proceeded	proceed	VBD	B-VP	O
to	to	TO	I-VP	O
undergo	undergo	VB	I-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Diabetes	Diabetes	NNP	B-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
and	and	CC	I-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Tubal	Tubal	JJ	B-NP	O
ligation	ligation	NN	I-NP	O
,	,	,	O	O
gastric	gastric	JJ	B-NP	O
stapling	stapling	NN	I-NP	O
for	for	IN	B-PP	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
Hickman	Hickman	NNP	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
HOME	HOME	NN	I-NP	O
:	:	:	O	O
Lovenox	Lovenox	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
30	30	CD	I-NP	O
IV	IV	CD	I-NP	O
continuously	continuously	RB	B-ADVP	O
,	,	,	O	O
dobutamine	dobutamine	NN	B-NP	O
5	5	CD	I-NP	O
IV	IV	CD	I-NP	O
cutaneously	cutaneously	RB	B-ADVP	O
,	,	,	O	O
milrinone	milrinone	NN	B-NP	O
0.3	0.3	CD	I-NP	O
mcg/kg	mcg/kg	NN	I-NP	O
/	/	SYM	B-NP	O
minute	minute	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
,	,	,	O	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
insulin	insulin	NN	I-NP	O
,	,	,	O	O
metolazone	metolazone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
probenecid	probenecid	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
thiamine	thiamine	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
1	1	CD	I-NP	O
gram	gram	NN	I-NP	O
IV	IV	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
MVI	MVI	NN	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
carnitine	carnitine	NN	B-NP	O
0.5	0.5	CD	B-NP	O
grams	gram	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Celexa	Celexa	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Medicine	Medicine	NNP	I-NP	O
Service	Service	NNP	I-NP	O
but	but	CC	B-PP	O
on	on	IN	B-PP	O
1/10/05	1/10/05	CD	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Cardiac	Cardiac	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
detailed	detail	VBN	B-NP	O
description	description	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
operative	operative	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
see	see	VB	B-VP	O
the	the	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
OP	OP	NN	I-NP	O
note	note	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Walklos	Walklos	NNP	I-NP	O
Ey	Ey	NNP	I-NP	O
Trham	Trham	NNP	I-NP	O
Aupids	Aupids	NNP	I-NP	O
Lubfranna	Lubfranna	NNP	I-NP	O
ICU	ICU	NNP	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

ICU	ICU	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
Neurological	Neurological	NNP	B-NP	O
:	:	:	O	O
Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
sedated	sedate	VBN	I-VP	O
on	on	IN	B-PP	O
propofol	propofol	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
intermittent	intermittent	JJ	B-NP	O
fentanyl	fentanyl	NN	I-NP	O
and	and	CC	O	O
Versed	Verse	VBN	B-VP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
towards	towards	IN	B-PP	O
extubation	extubation	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
sedating	sedate	VBG	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
Precedex	Precedex	NNP	B-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Precedex	Precedex	NN	I-NP	O
was	be	VBD	B-VP	O
eventually	eventually	RB	I-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
neurologically	neurologically	RB	B-ADVP	O
intact	intact	JJ	B-ADJP	O
but	but	CC	O	O
frequently	frequently	RB	B-ADJP	O
confused	confuse	VBN	I-ADJP	O
and	and	CC	O	O
often	often	RB	B-VP	O
disoriented	disorient	VBN	I-VP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
wean	wean	VB	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Celexa	Celexa	NNP	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Ativan	Ativan	NNP	B-NP	O
for	for	IN	B-PP	O
agitation	agitation	NN	B-NP	O
and	and	CC	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
neurologically	neurologically	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
neurological	neurological	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
confused	confuse	VBN	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
awake	awake	JJ	B-ADJP	O
,	,	,	O	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
to	to	TO	B-PP	O
person	person	NN	B-NP	O
,	,	,	I-NP	O
place	place	NN	I-NP	O
and	and	CC	I-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
completely	completely	RB	B-ADJP	O
appropriate	appropriate	JJ	I-ADJP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
speech	speech	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADVP	O
:	:	:	O	O
Shortly	Shortly	RB	B-ADVP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
operation	operation	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
profound	profound	JJ	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
milrinone	milrinone	NN	B-NP	O
with	with	IN	B-PP	O
successive	successive	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
slowly	slowly	RB	B-ADVP	O
her	her	PRP$	B-NP	O
pressors	pressor	NNS	I-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
moderate-to-severe	moderate-to-severe	JJ	B-NP	O
TR	TR	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
indentation	indentation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
atrium	atrium	NN	I-NP	O
with	with	IN	B-PP	O
respiration	respiration	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
pericardiocentesis	pericardiocentesis	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
clinically	clinically	RB	B-ADVP	O
in	in	IN	B-PP	O
tamponade	tamponade	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
for	for	IN	B-PP	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
still	still	RB	I-VP	O
pending	pende	VBG	I-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
diltiazem	diltiazem	NN	B-NP	O
15	15	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
milrinone	milrinone	NN	B-NP	B-protein
0.2	0.2	CD	I-NP	I-protein
.	.	.	O	O

Cardiology	Cardiology	NNP	B-NP	O
is	be	VBZ	B-VP	O
following	follow	VBG	I-VP	O
and	and	CC	O	O
plans	plan	NNS	B-VP	O
to	to	TO	I-VP	O
keep	keep	VB	I-VP	O
the	the	DT	B-NP	O
milrinone	milrinone	NN	I-NP	O
going	go	VBG	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
being	be	VBG	B-VP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
intubated	intubate	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
unstable	unstable	JJ	B-ADJP	O
and	and	CC	O	O
on	on	IN	B-PP	O
pressors	pressor	NNS	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
,	,	,	O	O
we	we	PRP	B-NP	O
weaned	wean	VBD	B-VP	O
towards	towards	IN	B-PP	O
extubation	extubation	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
successfully	successfully	RB	I-VP	O
extubated	extubate	VBN	I-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
n.p.o.	n.p.o.	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
seven	seven	CD	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
operation	operation	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
her	her	PRP$	B-NP	O
extubation	extubation	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
Dobbhoff	Dobbhoff	NNP	I-NP	O
feeding	feeding	NN	I-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
inserted	insert	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	B-cell_type
feeds	feed	NNS	I-NP	I-cell_type
until	until	IN	B-SBAR	I-cell_type
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
clear	clear	VB	I-VP	O
her	her	PRP$	B-NP	O
speech	speech	NN	I-NP	O
and	and	CC	I-NP	O
swallow	swallow	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
clearing	clear	VBG	B-VP	O
her	her	PRP$	B-NP	O
speech	speech	NN	I-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
evaluation	evaluation	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
minced	mince	VBN	B-NP	O
food	food	NN	I-NP	O
with	with	IN	B-PP	O
thickened	thicken	VBN	B-NP	O
liquids	liquid	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
signs	sign	NNS	I-NP	O
or	or	CC	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
advanced	advance	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
house	house	NN	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
thickened	thicken	VBN	B-NP	O
liquids	liquid	NNS	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
taking	take	VBG	I-VP	O
that	that	RB	B-ADVP	O
well	well	RB	I-ADVP	O
and	and	CC	O	O
having	have	VBG	B-VP	O
normal	normal	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
for	for	IN	B-PP	O
GI	GI	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

GU	GU	NN	B-NP	O
:	:	:	O	O
Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
lot	lot	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
wean	wean	VB	I-VP	O
her	her	PRP$	B-NP	O
pressors	pressor	NNS	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
aggressively	aggressively	RB	B-ADVP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
two	two	CD	I-NP	O
postoperative	postoperative	JJ	I-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
currently	currently	RB	B-ADVP	O
being	be	VBG	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
or	or	CC	O	O
receiving	receive	VBG	B-VP	O
large	large	JJ	B-NP	O
bolus	bolus	NN	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
has	have	VBZ	B-VP	O
trended	trend	VBN	I-VP	O
up	up	RP	B-PRT	O
minorly	minorly	RB	B-ADVP	O
postoperatively	postoperatively	RB	I-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
current	current	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
no	no	RB	I-VP	O
longer	longer	RB	I-VP	O
receiving	receive	VBG	I-VP	O
any	any	DT	B-NP	O
diuretics	diuretic	NNS	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
just	just	RB	I-VP	O
being	be	VBG	I-VP	O
managed	manage	VBN	I-VP	O
by	by	IN	B-PP	O
keeping	keep	VBG	B-VP	O
her	her	PRP$	B-NP	O
I	I	NN	I-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
O	O	NNP	B-NP	O
's	's	POS	B-NP	O
even	even	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
no	no	DT	B-NP	O
nephrotoxic	nephrotoxic	JJ	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
frequently	frequently	RB	B-ADJP	O
anemic	anemic	JJ	I-ADJP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
often	often	RB	B-VP	O
trending	trend	VBG	I-VP	O
downwards	downward	NNS	B-NP	O
to	to	TO	B-PP	O
levels	level	NNS	B-NP	O
as	as	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
as	as	IN	B-PP	O
20	20	CD	B-NP	O
or	or	CC	I-NP	O
21	21	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
transfused	transfuse	VBN	I-VP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
products	product	NNS	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
transfused	transfuse	VBN	I-VP	O
today	today	NN	B-NP	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
for	for	IN	B-PP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
21	21	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Niferex	Niferex	NNP	B-NP	O
for	for	IN	B-PP	O
iron	iron	NN	B-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
are	be	VBP	B-VP	O
considering	consider	VBG	I-VP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
erythropoietin	erythropoietin	NN	B-NP	B-protein
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
heme	heme	NN	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
and	and	CC	I-NP	O
Immunosuppression	Immunosuppression	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
immunosuppressed	immunosuppresse	VBN	I-VP	O
on	on	IN	B-PP	O
various	various	JJ	B-NP	O
different	different	JJ	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
current	current	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
is	be	VBZ	B-VP	O
Cellcept	Cellcept	JJ	B-NP	O
1500	1500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Neoral	Neoral	JJ	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
For	For	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
Valcyte	Valcyte	NN	B-NP	O
450	450	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Bactrim	Bactrim	NNP	B-NP	O
one	one	CD	I-NP	O
double	double	JJ	I-NP	O
strength	strength	NN	I-NP	O
tab	tab	NN	I-NP	O
q.o.d.	q.o.d.	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
nystatin	nystatin	NN	B-NP	O
swish	swish	VB	B-VP	O
and	and	CC	I-VP	O
swallow	swallow	VB	I-VP	O
and	and	CC	O	O
powders	powder	NNS	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
axilla	axilla	NN	I-NP	O
and	and	CC	I-NP	O
groin	groin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
spiked	spike	VBN	I-VP	O
any	any	DT	B-NP	O
temps	temp	NNS	I-NP	O
and	and	CC	I-NP	O
none	none	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
positive	positive	JJ	B-ADJP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
urinary	urinary	JJ	I-NP	O
culture	culture	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
Gram-negative	Gram-negative	JJ	B-NP	O
rods	rod	NNS	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
250	250	CD	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
very	very	RB	B-NP	O
difficult	difficult	JJ	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Portland	Portland	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
postoperatively	postoperatively	RB	B-PP	O
and	and	CC	I-PP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	O
drip	drip	NN	I-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
sugar	sugar	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

Diabetes	Diabetes	NNP	B-NP	O
Management	Management	NNP	I-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
assessing	assess	VBG	I-VP	O
her	her	PRP$	B-NP	O
daily	daily	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
needs	need	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
that	that	WDT	B-NP	O
consist	consist	VBP	B-VP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
every	every	DT	B-NP	O
evening	evening	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
Novolog	Novolog	NNP	B-NP	O
with	with	IN	B-PP	O
every	every	DT	B-NP	O
meal	meal	NN	I-NP	O
and	and	CC	O	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
coverage	coverage	NN	I-NP	O
with	with	IN	B-PP	O
Novolog	Novolog	NN	B-NP	O
for	for	IN	B-PP	O
meals	meal	NNS	B-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
are	be	VBP	B-VP	O
mildly	mildly	RB	I-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
but	but	CC	O	O
could	could	MD	B-VP	O
use	use	VB	I-VP	O
tighter	tight	JJR	B-NP	O
glycemic	glycemic	JJ	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Tubes	Tube	NNS	B-NP	O
,	,	,	O	O
Lines	Line	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Drains	Drain	NNS	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
wires	wire	NNS	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
tubes	tube	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
removed	remove	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
central	central	JJ	I-NP	O
access	access	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
just	just	RB	B-ADVP	O
has	have	VBZ	B-VP	O
peripherals	peripheral	NNS	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
TRANSFER	TRANSFER	NN	B-NP	O
:	:	:	O	O
Diltiazem	Diltiazem	NNP	B-NP	O
15	15	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
folic	folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Ativan	Ativan	NNP	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
agitation	agitation	NN	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
IV	IV	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
12h	12h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
nystatin	nystatin	NN	B-NP	O
5	5	CD	I-NP	O
ml	ml	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
MVI	MVI	NN	B-NP	O
therapeutic	therapeutic	JJ	B-ADJP	O
with	with	IN	B-PP	O
minerals	mineral	NNS	B-NP	O
,	,	,	O	O
thiamine	thiamine	NN	B-NP	O
hydrochloride	hydrochloride	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
thiamine	thiamine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
milrinone	milrinone	NN	B-NP	O
IV	IV	CD	I-NP	O
0.2	0.2	CD	I-NP	O
mcg/kg/minute	mcg/kg/minute	NN	I-NP	O
,	,	,	O	O
Neoral	Neoral	JJ	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Bactrim	Bactrim	NNP	B-NP	O
DS	DS	NNP	I-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Cellcept	Cellcept	NNP	B-NP	O
1500	1500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
levoflox	levoflox	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
x7	x7	NN	I-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
2	2	CD	I-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
TP	TP	NN	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
and	and	CC	O	O
Celexa	Celexa	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Valcyte	Valcyte	NNP	B-NP	O
450	450	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
30	30	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
DuoNeb	DuoNeb	NNP	B-NP	O
q.	q.	NNP	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Novolog	Novolog	NNP	B-NP	O
4	4	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
,	,	,	O	O
Novolog	Novolog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
,	,	,	O	O
Novolog	Novolog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
subq	subq	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Novolog	Novolog	NN	B-NP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
step-down	step-down	JJ	I-NP	B-DNA
unit	unit	NN	I-NP	I-DNA
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-2798139	8-2798139	CD	B-NP	O
EMS	EMS	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
CHAFFEY	CHAFFEY	NNP	B-NP	O
,	,	,	O	O
JC	JC	NNP	B-NP	O
WARNER	WARNER	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LOTRIDGE	LOTRIDGE	NN	B-NP	O
,	,	,	O	O
MARVIN	MARVIN	NNP	B-NP	O
CHRISTOPHER	CHRISTOPHER	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9844371	9844371	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/18/05	3/18/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/18/05	3/18/05	CD	B-NP	O

